People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Theraclone Sciences, Inc. | — | Biotechnology | Series A | $36.7M | $111.3M | 2010 |
David Fanning at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Fanning on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Gillis | 1 | 23 |
| Wende Hutton | 1 | 16 |
| Christopher Mirabelli | 1 | 6 |
| William Greene | 1 | 6 |
| Clifford Stocks | 1 | 5 |
| Wendye Robbins | 1 | 3 |
| Russ Hawkinson | 1 | 2 |
| Kristine Swiderek | 1 | 2 |
| Eleanor Ramos | 1 | 1 |
| Witold Cieplak | 1 | 1 |
| Teri Koller | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.